Adding white blood cell count and polymorphonuclear leukocyte differential to already existing ultrasound screening technology improves predictive diagnosis of appendicitis in children, according to a study published online Jan. 31 in the Journal of the American College of Surgeons.

ROCHESTER, N.Y., Feb. 26 — Carestream Health’s newest DRX imaging system—the CARESTREAM DRX-Evolution Plus—adds several major software and hardware enhancements to meet the changing radiology needs and budgets of healthcare providers worldwide.

At ECR 2015 Esaote, a world leading manufacturer of medical diagnostic systems, introduces Evolution’15 (EVO’15) as the latest upgrade in its dedicated MRI Evolution program. EVO’15 combines software updates and new hardware features to provide superb image quality and increases productivity by almost 50 percent.

A new addition to the cryogen-free, preclinical MRI imaging family, the 4.7T model, is now available to order. It joins the 3T and 7T systems for superior soft tissue contrast and molecular imaging research. This has been brought to the market by MR Solutions, the world’s largest independent developer and manufacturer of commercially available MRI technology. MR Solutions, which pioneered the cryogen free technology in 2013, is the only company to have delivered this technology to customers across the world.

ROSELLE, IL, Feb. 24, 2015 — Planmed announced today that effective November 15, 2014, its Planmed Verity® extremity CT scanner is available on the Novation Merry-X-Ray capital equipment and diagnostics imaging distribution contract (XR0262), effective through July 31, 2017.

LONG ISLAND, N.Y., Feb. 25, 2015 —  Medical equipment manufacturer Quantum Medical Imaging has completed the installation of Quantum a Q-Rad-DIGITAL DRX Radiographic System at the Burbank Advanced Imaging Center. The sale and installation was facilitated by Spectrum Medical X-Ray Company, which is a certified Quantum/Carestream Dealer.

Providing women with more comprehensive information about overdiagnosis as it relates to mammography screening can help them make an informed choice, which might mean a decision to forgo screening altogether, according to an Australian study published online Feb. 18 in The Lancet.

Men with indolent prostate cancer are prescribed radiation therapy more than any other treatment option regardless of tumor biology, according to a study published in the February issue of JAMA Oncology.